Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, RNA Interference and Gene Delivery, and Immunotherapy and Immune Responses.
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques
Phase 1b/2 study of margetuximab (M) plus pembrolizumab (P) in advanced HER2+ gastroesophageal junction (GEJ) or gastric (G) adenocarcinoma (GEA).